These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14076792)

  • 1. HEMOCHROMATOSIS SECONDARY TO LIVER DISEASE AND IRON INGESTION.
    PASCAL RR; EINSPRUCH BC
    N Y State J Med; 1963 Oct; 63():2825-33. PubMed ID: 14076792
    [No Abstract]   [Full Text] [Related]  

  • 2. HISTOGENESIS OF THE HEPATIC LESION IN PRIMARY HEMOCHROMATOSIS: WITH CONSIDERATION OF THE PSEUDO-IRON DEFICIENT STATE PRODUCED BY PHLEBOTOMIES.
    BLOCK M; MOORE G; WASI P; HAIBY G
    Am J Pathol; 1965 Jul; 47(1):89-123. PubMed ID: 14308140
    [No Abstract]   [Full Text] [Related]  

  • 3. STUDIES IN IRON ABSORPTION. III. BODY RADIOACTIVITY MEASUREMENTS OF PATIENTS WITH LIVER DISEASE.
    GREENBERG MS; STROHMEYER G; HINE GJ; KEENE WR; CURTIS G; CHALMERS TC
    Gastroenterology; 1964 Jun; 46():651-61. PubMed ID: 14173923
    [No Abstract]   [Full Text] [Related]  

  • 4. [SECONDARY HEMOCHROMATOSIS AFTER PARENTERAL ADMINISTRATION OF IRON].
    DIESKA D
    Bratisl Lek Listy; 1963; 43():535-40. PubMed ID: 14060898
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic cirrhosis and hemochromatosis in three horses.
    Pearson EG; Hedstrom OR; Poppenga RH
    J Am Vet Med Assoc; 1994 Apr; 204(7):1053-6. PubMed ID: 8045806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The daily variations in serum iron and latent iron binding capacity in hepatitis, liver cirrhosis, alcoholism, hemochromatosis and aplastic anemia].
    Speck B
    Schweiz Med Wochenschr; 1970 Feb; 100(7):303-5. PubMed ID: 5413919
    [No Abstract]   [Full Text] [Related]  

  • 7. TREATMENT OF PRIMARY AND SECONDARY HEMOCHROMATOSIS AND ACUTE IRON POISONING WITH A NEW POTENT IRON ELIMINATING AGENT (DESFERRIOXAMINE B-DFOM).
    MOESCHLIN S; SCHNIDER U
    Ned Tijdschr Geneeskd; 1964 Aug; 108():1648-53. PubMed ID: 14222009
    [No Abstract]   [Full Text] [Related]  

  • 8. THE MECHANISM OF ANAEMIA IN CHRONIC LIVER DISEASE.
    KIMBER C; DELLER DJ; IBBOTSON RN; LANDER H
    Q J Med; 1965 Jan; 34():33-64. PubMed ID: 14252426
    [No Abstract]   [Full Text] [Related]  

  • 9. [THE HEMOCHROMATOSIS-MEGALOBLASTIC ANEMIA ASSOCIATION. APROPOS OF 2 CASES].
    DE GRAILLY R; LEGER H; KERMAREC J; LASSERRE M
    J Med Bord; 1963 Sep; 140():1317-33. PubMed ID: 14090754
    [No Abstract]   [Full Text] [Related]  

  • 10. HISTOLOGIC AND CHEMICAL TISSUE IRON. SIGNIFICANCE FOR HEMOCHROMATOSIS.
    PECHET GS; FRENCH SW; LEVY J; MACDONALD RA
    Arch Pathol; 1965 May; 79():452-61. PubMed ID: 14288996
    [No Abstract]   [Full Text] [Related]  

  • 11. PARENCHYMAL SIDEROSIS IN PATIENTS WITH PREEXISTING PORTAL CIRRHOSIS. A PATHOLOGIC ENTITY SIMULATING IDIOPATHIC AND TRANSFUSIONAL HEMOCHROMATOSIS.
    SABESIN SM; THOMAS LB
    Gastroenterology; 1964 Apr; 46():477-85. PubMed ID: 14141787
    [No Abstract]   [Full Text] [Related]  

  • 12. STUDIES OF COPROPORPHYRIN. VIII. REINVESTIGATION OF THE ISOMER DISTRIBUTION IN JAUNDICE AND LIVER DISEASES.
    AZIZ MA; SCHWARTZ S; WATSON CJ
    J Lab Clin Med; 1964 Apr; 63():596-604. PubMed ID: 14155448
    [No Abstract]   [Full Text] [Related]  

  • 13. [THE SIGNIFICANCE OF SERUM IRON CONTENT AND IRON-BINDING PROTEIN IN THE DIFFERENTIAL DIAGNOSIS OF VARIOUS DISEASES].
    BRUESCHKE G; HERRMANN H; ISRAEL S
    Z Arztl Fortbild (Jena); 1964 Feb; 58():142-6. PubMed ID: 14151714
    [No Abstract]   [Full Text] [Related]  

  • 14. [RESEARCH ON DESFERRIOXAMINE B. 3. THE CLINICAL USE OF DESFERRIOXAMINE B].
    VENTURA S; COLI L
    Haematologica; 1964; 49():252-73. PubMed ID: 14217827
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental pigment cirrhosis: its production in rats by feeding a choline-deficient diet with excess iron.
    MACDONALD RA
    Am J Pathol; 1960 May; 36(5):499-519. PubMed ID: 14419332
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemochromatosis (apropos of 100 cases)].
    Darnis F
    Ann Biol Clin (Paris); 1972; 30(4):349-78. PubMed ID: 5082971
    [No Abstract]   [Full Text] [Related]  

  • 17. [A NEW TEST FOR ASCERTAINMENT OF STATES OF SIDEROSIS: THE DESFERRIOXAMINE TEST. PRELIMINARY RESULTS].
    SCURO LA; BROCCIA G; DOBRILLA G; TAGLIAMONTE A
    Policlinico Prat; 1964 Jul; 71():1101-13. PubMed ID: 14174378
    [No Abstract]   [Full Text] [Related]  

  • 18. [INFLUENCE OF DESFERRIOXAMINE ON THE URINARY ELIMINATION OF IRON IN NORMAL AND PATHOLOGICAL SUBJECTS].
    MARCACCI M; CICALA P; GUIDONE M; NAPPI L; DIMARTINO G
    Clin Ter; 1964 Jan; 28():105-19. PubMed ID: 14122514
    [No Abstract]   [Full Text] [Related]  

  • 19. THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE.
    WOEHLER F
    Acta Haematol; 1963 Aug; 30():65-87. PubMed ID: 14064792
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemochromatosis secondary to liver diseases].
    Paraf A; Coste T; Rautureau J
    Ann Med Interne (Paris); 1971 Dec; 122(12):1217-24. PubMed ID: 5170223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.